65,437 trials
Familial Chylomicronemia Syndrome · Lipoprotein Lipase Deficiency · Hyperlipoproteinemia Type 1
Primary: Absolute Change From Baseline to Month 3 in Fasting Triglycerides (TG) — -550.00 mg/dL
Stem Cell Transplantation · Leukemia
Primary: Number of Participants With Molecular Response — 8; 0; 4 Participants
Rheumatoid Arthritis
Primary: Maximum Observed Serum Concentration (Cmax) — 237.0341; 236.2882 ug/mL
Old World Cutaneous Leishmaniasis
Primary: Safety: Overview of Adverse Events — 16; 7; 0; 0 Participants
Anal Chlamydia Infection
Primary: The Proportion of Subjects With Microbiologic Cure (Negative Rectal CT NAAT Result) at Day 29 — 0.74; 1.00 proportion of participants — p=<0.001
Distress · Depression · Grief
Primary: Number of Participants Who Experienced Treatment-related Adverse Events as Assessed by NIH Division of AIDS Table for Grading the Severity of Adult and Pediatric Adverse…
Wound Healing Disturbance of
Primary: Wound Re-epithelization — 12.34; 10.27; 11.33 days
Asthma
Primary: Change in Percent of Eosinophils in Sputum 7 Hours Post Allergen Challenge — 0.822; 6.468 Percent — p=0.0208
Sickle Cell Disease
Primary: Number of Participants With Increase in Hb >1 g/dL From Baseline to Week 24 — 30; 46; 6 Participants
COVID-19 · Pregnancy Complications · Mental Health Wellness 1
Primary: Number of Participants With Symptoms of Post-traumatic Stress Disorder — 1028; 532 Participants
Dental Caries
Primary: International Caries Detection and Assessment System (ICDAS II) - Number of Molars With ICDAS Score of 3 or More - ICDAS Score 3, Cavity - — 0; 13 right or left second…
Oral Malodor
Primary: Change in Malodor as Measured by Organoleptic Score — 3.09; 3.08; 3.03; 3.23 score on a scale — p=<0.010
Triple-Negative Breast Cancer
Primary: Progression-Free Survival (PFS) Assessed Using Response Evaluation Criteria in Solid Tumors Version 1.1 (RECIST v1.1) in the Subpopulation With Programmed Death-Ligand 1…
Intermittent Claudication
Primary: Change in Peak Walking Time (PWT) From Baseline — 5.394; 5.712; 1.121; 1.493 minutes — p=0.727
Cardiac Disease
Primary: Absolute Value of LVEF Percentage Differences From CMR by Blinded Reader — 5.70; 5.88; 5.03; 6.08 Percent Ejection Fraction — p=0.358